NUF2 and cancer: As we previously reported [14], the CDCA155-78 peptide is naturally processed from CDCA1 protein by dendritic cells to induce HLA-DR4-restricted Th-cell responses in human PBMCs isolated from HLA-DR4-positive healthy donors and cancer patients.